Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Jae Hyun BaeSunhee KimEun Gee ParkSin Gon KimSeokyung HahnNam Hoon KimPublished in: Endocrinology and metabolism (Seoul, Korea) (2020)
DPP-4 inhibitors had beneficial renal effects mainly by reducing the risk of development or progression of albuminuria compared with placebo or other antidiabetic agents.
Keyphrases